leflunomide sandoz
lex ano, uab - leflunomidas - plėvele dengtos tabletės - 20 mg - leflunomide
leflunomida farmoz
edupharma, uab - leflunomidas - plėvele dengtos tabletės - 20 mg - leflunomide
leflunomide elvim
sia elvim - leflunomidas - plėvele dengtos tabletės - 10 mg - leflunomide
leflunomide elvim
sia elvim - leflunomidas - plėvele dengtos tabletės - 20 mg - leflunomide
zeposia
bristol-myers squibb pharma eeig - ozanimod hidrochloridas - multiple sclerosis, relapsing-remitting; colitis, ulcerative - imunosupresantai - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.
crestor
lex ano, uab - rozuvastatinas - plėvele dengtos tabletės - 10 mg - rosuvastatin
crestor
lex ano, uab - rozuvastatinas - plėvele dengtos tabletės - 20 mg - rosuvastatin
dimethyl fumarate mylan
mylan ireland limited - dimetilfumaratas - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantai - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetilfumaratas - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantai - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dimetilfumaratas - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantai - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.